在因精神分裂症住院的患者中,临床和生化参数的性别差异:走向精准医学
Cecilia Maria Esposito1,2, Francesca De Cagna3, Alice Caldiroli4
1Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy. ceciliam.esposito@hotmail.com.
概括
这项研究发现精神分裂症的性别差异,男性出现更早的发病和更高的物质使用,而女性经历了更多的代谢问题,如高胆固醇血症. 这些发现支持量身定制的精神分裂症治疗策略.
科学领域:
- 精神病学是一个精神病学.
- 临床心理学 临床心理学
- 生物化学 生化学
背景情况:
- 精神分裂症在临床进展中表现出已知的基于性别的变异.
- 了解这些差异对于开发个性化治疗方法至关重要.
研究的目的:
- 研究精神分裂症患者临床和生化参数的性别特异性差异.
- 确定可能为精神分裂症提供个性化治疗策略的因素.
主要方法:
- 分析了一组555名精神分裂症患者的队列,这些患者在2008年至2021年期间因症状恶化而入院.
- 从图表和血液分析中收集了临床数据.
- 采用了包括单变量和逻辑回归分析在内的统计方法,将性别作为依赖变量.
主要成果:
- 男性患者出现了更早的发病年龄,更高的物质使用障碍,吸烟和精神伴随性疾病率.
- 女性的临床状况较为不严重,发病时间较晚,并具有较低的并发症,但更容易发生甲状腺功能低下和高胆固醇血症.
- 生物化学差异包括较高的白蛋白和白血素,以及男性较低的总胆固醇.
结论:
- 女性精神分裂症患者的临床过程似乎不那么严重,特别是在早期发病和并发症方面.
- 雌性对代谢障碍的脆弱性增加,包括甲状腺功能障碍和高胆固醇.
- 需要进一步的研究,在精准医学框架内验证这些性别特异性发现.
相关概念视频
Biological Causes of Schizophrenia
103
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
103
Psychological and Sociocultural Causes of Schizophrenia
142
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
142
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
755
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
755
Psychosis: Goals of Pharmacotherapy
170
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
170
Human Genetics
616
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
616
Factors Affecting Drug Biotransformation: Biological
180
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
180


